CClinicalTrials.gg
CompletedNCT02609373ICOSUpdated Nov 3, 2016

Improving Cancer-Related Outcomes in Shift Workers

An interventional study of Sleep intervention in Breast Cancer, sponsored by University of British Columbia. Completed at 1 site in Canada. Open to female participants aged 40 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-11-03.

Sponsored by University of British Columbia · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
47
Allocation
Not applicable
Ages
40 Years to 65 Years
Sex
Female
01

Study summary

Shift work with circadian disruption has been linked with increased breast cancer incidence. The mechanisms for this effect are not yet completely understood.

This study evaluates the impact of a previously developed sleep intervention in shift workers at risk of breast cancer; and assesses mediating variables that may explain the relationship between shift work and breast cancer.

A sample of women night shift workers were provided with a sleep intervention. The intervention is a standard approach used in a sleep clinic and is delivered by telephone by a trained intervener.

Hypothesis: The intervention will improve sleep in women night shift workers, which will in turn have a positive impact on biological and behavioural risk factors associated with breast cancer and quality of life.

Read the detailed description

47 female night shift workers completed a sleep intervention. The intervention follows an established sleep therapy protocol. Assessments at baseline, 6 and 12 months include mammographic density and possible mediating variables known to be linked to breast cancer risk including behavioural, biometric, and biological measures. Behavioural and self-report measures of sleep quality and physical activity are assessed as well as self-reported chronotype and quality of life.

The intervention is a multi-session intervention using cognitive behavioural principles to increase healthy sleep by addressing a variety of behaviours that may influence sleep quality and quantity, based an established telephone-based protocol used at the UBC Hospital Sleep Disorders Clinic. It includes 10 telephone sessions spaced over a 6-month period, and 2 additional booster sessions at 8 and 10 months. Participants are given a sleep diary at baseline to complete for 2 weeks before the sleep hygiene telephone counseling session begins.

The intervention protocol incorporates sleep assessment, maintaining a sleep diary and use of an actiwatch (to measure sleep and physical activity), sleep hygiene (i.e., controlling behavioural and environmental factors that affect sleep), stimulus control therapy (i.e., teaching individuals how to eliminate behaviours that are incompatible with sleep), sleep restriction therapy (i.e., teaching how to limit time in bed to time asleep), cognitive restructuring (i.e., modifying non-adaptive thoughts and triggers for insomnia), and relapse prevention. The structured counseling protocol includes concrete exercises and activities, questions and answers, and problem solving strategies.

Medication use is not part of this protocol; if participants wish to explore pharmacologic approaches, they are advised to consult with their physicians. Although some shift workers have received care from the Sleep Clinic in the past, there has not been a systematic focus on this group.

The project manager conducts a telephone-based evaluation of the intervention 6 months post-sleep intervention. Blood and salivary samples are collected using standardized data collection methods at baseline, 6, and 12 months, and mammographic films are collected at baseline and 12 months.

02

Conditions studied

  • Breast Cancer

Browse trials for

Keywords

  • shiftwork
  • sleep hygiene
  • prevention
  • intervention
  • occupational
  • biological
  • breast cancer
  • lifestyle
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 47 is below the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Women aged 40-65 years
  • Working or living in Greater Vancouver Area
  • Read and understand English
  • Work rotating or permanent night shift at least 3 times per month, for at least 2 years
  • Received a screening mammogram within the past 3 years

Exclusion criteria

Exclusion Criteria:

  • History of breast cancer
  • On active cancer therapy for any cancer
  • Pregnant
  • Diabetes requiring drug treatment
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
47 participants (actual)

Study arms

  • Other
    Sleep intervention

    Sleep intervention

    Behavioral: Sleep intervention

Interventions

  • BehavioralSleep intervention

    Session 1: Intervener \& participant review 2-week sleep diary and actigraph data. Provide individualized sleep hygiene prescription. Session 2: Review sleep diary; calculate sleep efficiency; identify adjustments needed. Session 3: Review sleep-related vs. stress-related symptoms. Develop plan for sleep-related symptoms and discuss "Sleep Restriction with Relaxation Exercises." Session 4: Reinforce progress and make corrections as required. If Sleep Restriction is not working, Stimulus Control is introduced. Session 5-10: Provide reinforcement, assess adherence, answer questions, and offer encouragement and monitoring, including alterations as required. Booster sessions: At 8 \& 10 months: reinforcement, question answering, encouragement and monitoring.

06

What researchers measure

Primary outcomes

  1. Change in sleep quality

    Self-reported "good" sleep quality at baseline and 6 months

    Time frame: Baseline, 6 months

Secondary outcomes

  1. Change in melatonin

    Change in melatonin at baseline and 6 months

    Time frame: Baseline, 6 months

  2. Change in melatonin

    Change in melatonin at 6 and 12 months

    Time frame: 6 months, 12 months

  3. Change in melatonin

    Change in melatonin at baseline and 12 months

    Time frame: Baseline, 12 months

  4. Change in cortisol

    Change in cortisol at baseline and 6 months

    Time frame: Baseline, 6 months

  5. Change in cortisol

    Change in cortisol at 6 and 12 months

    Time frame: 6 months, 12 months

  6. Change in cortisol

    Change in cortisol at baseline and 12 months

    Time frame: Baseline, 12 months

  7. Change in breast density

    Change in breast density at baseline and 12 months

    Time frame: Baseline, 12 months

  8. Change in IGF-1 and IGFBP 1,2,3,7

    Change in IGF-1 and IGFBP 1,2,3,7 at baseline and 6 months

    Time frame: Baseline, 6 months

  9. Change in IGF-1 and IGFBP 1,2,3,7

    Change in IGF-1 and IGFBP 1,2,3,7 at 6 and 12 months

    Time frame: 6 months,12 months

  10. Change in IGF-1 and IGFBP 1,2,3,7

    Change in IGF-1 and IGFBP 1,2,3,7 at baseline and 12 months

    Time frame: Baseline, 12 months

  11. Change in Vitamin D

    Change in Vitamin D at baseline and 6 months

    Time frame: Baseline, 6 months

  12. Change in Vitamin D

    Change in Vitamin D at 6 and 12 months

    Time frame: 6 months, 12 months

  13. Change in Vitamin D

    Change in Vitamin D at baseline and 12 months

    Time frame: Baseline, 12 months

  14. Change in C-reactive protein

    Change in C-reactive protein from baseline to 6 months

    Time frame: Baseline, 6 months

  15. Change in C-reactive protein

    Change in C-reactive protein from 6 to 12 months

    Time frame: 6 months and 12 months

  16. Change in C-reactive protein

    Change in C-reactive protein from baseline to 12 months

    Time frame: Baseline, 12 months

  17. Change in insulin

    Change in insulin from baseline to 6 months

    Time frame: Baseline, 6 months

  18. Change in insulin

    Change in insulin from 6 to 12 months

    Time frame: 6 months and 12 months

  19. Change in insulin

    Change in insulin from baseline to 12 months

    Time frame: Baseline, 12 months

  20. Change in glucose

    Change in glucose from baseline to 6 months

    Time frame: Baseline, 6 months

  21. Change in glucose

    Change in glucose from 6 to 12 months

    Time frame: 6 months and 12 months

  22. Change in glucose

    Change in glucose from baseline to 12 months

    Time frame: Baseline, 12 months

  23. Change in quality of life

    Change in quality of life from baseline to 6 months

    Time frame: Baseline, 6 months

  24. Change in quality of life

    Change in quality of life from 6 months to 12 months

    Time frame: 6 months, 12 months

  25. Change in quality of life

    Change in quality of life from baseline to 12 months

    Time frame: Baseline,12 months

  26. Intervention Evaluation

    Participant satisfaction and perceptions of intervention assessed by semi-structured telephone interview

    Time frame: 12 months

  27. Change in sleep quality

    Self-reported "good" sleep quality at 6 and 12 months

    Time frame: 6 months, 12 months

  28. Change in sleep quality

    Self-reported "good" sleep quality at baseline and 12 months

    Time frame: Baseline, 12 months

  29. Change in health and lifestyle

    Change in self-reported health and lifestyle assessed by structured questionnaire at baseline and 6 months

    Time frame: Baseline, 6 months

  30. Change in health and lifestyle

    Change in self-reported health and lifestyle assessed by structured questionnaire at 6 and 12 months

    Time frame: 6 months, 12 months

  31. Change in health and lifestyle

    Change in self-reported health and lifestyle assessed by structured questionnaire at baseline and 12 months

    Time frame: Baseline, 12 months

Other outcomes

  1. Concordance between self-reported sleep quality and other indicators

    Comparison of ratings between self-reports, diary data, and actigraph readings at all time points

    Time frame: Baseline, 6 months, 12 months

07

Study locations

1 site
  • University of British Columbia
    Vancouver, British Columbia V6T1Z3, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 3, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02609373
Lead sponsor
University of British Columbia
Collaborators
Canadian Cancer Society (CCS)
Responsible party
Carolyn Gotay (Professor, University of British Columbia) — Principal investigator
First posted
Nov 20, 2015
Start date
Jul 2011
Primary completion
Apr 2015
Completion
Jan 2016
Last update
Nov 3, 2016

Study contacts

Carolyn Gotay, PhD.
principal investigator · The Univeristy of British Columbia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion